[HTML][HTML] Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta …

I Mintziras, M Miligkos, S Waechter… - International Journal of …, 2018 - Elsevier
Backround The role of sarcopenia and sarcopenic obesity in patients with pancreatic ductal
adenocarcinoma (PDAC) remains controversial. Material and Methods Medline and Web of …

Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis

I Mintziras, M Miligkos, S Wächter, J Manoharan… - 2018 - ir.lib.uth.gr
Backround: The role of sarcopenia and sarcopenic obesity in patients with pancreatic ductal
adenocarcinoma (PDAC) remains controversial. Material and Methods: Medline and Web of …

[引用][C] Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta …

I Mintziras, M Miligkos, S Wächter… - International Journal of …, 2018 - cir.nii.ac.jp
Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in
patients with pancreatic cancer: Systematic review and meta-analysis | CiNii Research CiNii …

Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis.

I Mintziras, M Miligkos, S Wächter… - … Journal of Surgery …, 2018 - europepmc.org
Results Eleven studies comprising 2.297 patients were considered suitable for inclusion.
Overall 959 of 2.111 (45.4%) patients were defined as sarcopenic and 163 of 1.254 (13%) …

Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis

I Mintziras, M Miligkos, S Wächter… - … Journal of Surgery, 2018 - journals.lww.com
Results Eleven studies comprising 2.297 patients were considered suitable for inclusion.
Overall 959 of 2.111 (45.4%) patients were defined as sarcopenic and 163 of 1.254 (13%) …

Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis

I Mintziras, M Miligkos, S Wächter… - … journal of surgery …, 2018 - pubmed.ncbi.nlm.nih.gov
Backround The role of sarcopenia and sarcopenic obesity in patients with pancreatic ductal
adenocarcinoma (PDAC) remains controversial. Material and methods Medline and Web of …